InvestorsHub Logo
Followers 1008
Posts 43490
Boards Moderated 0
Alias Born 03/17/2014

Re: Yukon post# 35366

Friday, 01/13/2017 10:46:58 PM

Friday, January 13, 2017 10:46:58 PM

Post# of 203913
large pharmaceutical companies have come to realize that they wont be able to compete with medical cannabis in the long run.


medical cannabis is here to stay.



so take a company like Teva: it is making a move into medical cannabis already by investing millions in it.


next step is buying out small companies before they become too large.


gwph is a buyout candidate already. somebody is going to snatch them up.

goldman sachs has already placed a price tag on that acquisition:


they believe that gwph can command $349 a share acquisition value.



that is steep but that is probably what somebody will have to pay to snatch up gwph.


that is why large companies will get smart fast and start scooping up small companies with promising technology and promising future sooner rather than later.


i think that is one of the reasons why OWCP is skyrocketing.


sooner or later OWCP is an attractive acquisition target.